The role of purinergic receptors in cancer-induced bone pain

Research output: Contribution to journalReviewResearchpeer-review

Standard

The role of purinergic receptors in cancer-induced bone pain. / Falk, Sarah; Uldall, Maria; Heegaard, Anne-Marie.

In: Journal of Osteoporosis, 2012, p. Article ID 758181.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Falk, S, Uldall, M & Heegaard, A-M 2012, 'The role of purinergic receptors in cancer-induced bone pain', Journal of Osteoporosis, pp. Article ID 758181. https://doi.org/10.1155/2012/758181

APA

Falk, S., Uldall, M., & Heegaard, A-M. (2012). The role of purinergic receptors in cancer-induced bone pain. Journal of Osteoporosis, Article ID 758181. https://doi.org/10.1155/2012/758181

Vancouver

Falk S, Uldall M, Heegaard A-M. The role of purinergic receptors in cancer-induced bone pain. Journal of Osteoporosis. 2012;Article ID 758181. https://doi.org/10.1155/2012/758181

Author

Falk, Sarah ; Uldall, Maria ; Heegaard, Anne-Marie. / The role of purinergic receptors in cancer-induced bone pain. In: Journal of Osteoporosis. 2012 ; pp. Article ID 758181.

Bibtex

@article{4ef5d0b6583d44408ddecc18ec740b4d,
title = "The role of purinergic receptors in cancer-induced bone pain",
abstract = "Cancer-induced bone pain severely compromises the quality of life of many patients suffering from bone metastasis, as current therapies leave some patients with inadequate pain relief. The recent development of specific animal models has increased the understanding of the molecular and cellular mechanisms underlying cancer-induced bone pain including the involvement of ATP and the purinergic receptors in the progression of the pain state. In nociception, ATP acts as an extracellular messenger to transmit sensory information both at the peripheral site of tissue damage and in the spinal cord. Several of the purinergic receptors have been shown to be important for the development and maintenance of neuropathic and inflammatory pain, and studies have demonstrated the importance of both peripheral and central mechanisms. We here provide an overview of the current literature on the role of purinergic receptors in cancer-induced bone pain with emphasis on some of the difficulties related to studying this complex pain state.",
author = "Sarah Falk and Maria Uldall and Anne-Marie Heegaard",
note = "Article ID 758181",
year = "2012",
doi = "10.1155/2012/758181",
language = "English",
pages = "Article ID 758181",
journal = "Journal of Osteoporosis",
issn = "2090-8059",
publisher = "Hindawi Publishing Corporation",

}

RIS

TY - JOUR

T1 - The role of purinergic receptors in cancer-induced bone pain

AU - Falk, Sarah

AU - Uldall, Maria

AU - Heegaard, Anne-Marie

N1 - Article ID 758181

PY - 2012

Y1 - 2012

N2 - Cancer-induced bone pain severely compromises the quality of life of many patients suffering from bone metastasis, as current therapies leave some patients with inadequate pain relief. The recent development of specific animal models has increased the understanding of the molecular and cellular mechanisms underlying cancer-induced bone pain including the involvement of ATP and the purinergic receptors in the progression of the pain state. In nociception, ATP acts as an extracellular messenger to transmit sensory information both at the peripheral site of tissue damage and in the spinal cord. Several of the purinergic receptors have been shown to be important for the development and maintenance of neuropathic and inflammatory pain, and studies have demonstrated the importance of both peripheral and central mechanisms. We here provide an overview of the current literature on the role of purinergic receptors in cancer-induced bone pain with emphasis on some of the difficulties related to studying this complex pain state.

AB - Cancer-induced bone pain severely compromises the quality of life of many patients suffering from bone metastasis, as current therapies leave some patients with inadequate pain relief. The recent development of specific animal models has increased the understanding of the molecular and cellular mechanisms underlying cancer-induced bone pain including the involvement of ATP and the purinergic receptors in the progression of the pain state. In nociception, ATP acts as an extracellular messenger to transmit sensory information both at the peripheral site of tissue damage and in the spinal cord. Several of the purinergic receptors have been shown to be important for the development and maintenance of neuropathic and inflammatory pain, and studies have demonstrated the importance of both peripheral and central mechanisms. We here provide an overview of the current literature on the role of purinergic receptors in cancer-induced bone pain with emphasis on some of the difficulties related to studying this complex pain state.

U2 - 10.1155/2012/758181

DO - 10.1155/2012/758181

M3 - Review

SP - Article ID 758181

JO - Journal of Osteoporosis

JF - Journal of Osteoporosis

SN - 2090-8059

ER -

ID: 45847063